Medical Transcription Billing Corp (NASDAQ:MTBC) General Counsel Shruti H. Patel sold 12,291 shares of the stock in a transaction that occurred on Wednesday, September 12th. The stock was sold at an average price of $4.61, for a total value of $56,661.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

NASDAQ MTBC traded down $0.07 on Thursday, reaching $4.58. 447 shares of the stock traded hands, compared to its average volume of 124,768. The firm has a market cap of $56.27 million, a P/E ratio of -35.38 and a beta of 1.73. Medical Transcription Billing Corp has a 12 month low of $1.39 and a 12 month high of $5.44.

Medical Transcription Billing (NASDAQ:MTBC) last issued its quarterly earnings results on Wednesday, August 8th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.09). The firm had revenue of $8.68 million during the quarter, compared to analyst estimates of $8.39 million. Medical Transcription Billing had a positive return on equity of 2.01% and a negative net margin of 2.73%. analysts predict that Medical Transcription Billing Corp will post -0.5 EPS for the current year.

Separately, HC Wainwright set a $6.00 price target on Medical Transcription Billing and gave the company a “buy” rating in a research note on Monday, August 13th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $3.92.

An institutional investor recently bought a new position in Medical Transcription Billing stock. Dimensional Fund Advisors LP purchased a new stake in shares of Medical Transcription Billing Corp (NASDAQ:MTBC) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 27,909 shares of the technology company’s stock, valued at approximately $108,000. Dimensional Fund Advisors LP owned approximately 0.24% of Medical Transcription Billing as of its most recent filing with the SEC. 5.84% of the stock is currently owned by hedge funds and other institutional investors.

Medical Transcription Billing Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Read More: What is a Leveraged Buyout (LBO)?

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with's FREE daily email newsletter.